Originally trained in systems engineering at UCLA, Dr. Neal Eigler attended Yale Medical School and was a Cardiovascular Fellow at Cedars-Sinai Hospital. Alongside Dr. Frank Litvack, he served as Co-Director of Cardiac Intervention at Cedars-Sinai for more than two decades, holding the academic rank of Professor of Medicine at UCLA.
Dr. Eigler has 44 issued U.S. patents for medical devices. He was a Co-Founder and/or Medical Director of Progressive Angioplasty System (PAS) and Conor MedSystems, where he co-invented the multi-drug delivery stent platform with programmable elution kinetics. In 2000, Dr. Eigler founded and served as CEO at Savacor, a developer of an implantable left atrial pressure sensing system that was linked to a real-time patient self-management system for treating heart failure. After the acquisition of the company, he remained with St. Jude (acquiring company) as a Senior Vice President of Technology Incubation from 2006 through 2014.
Since joining V-Wave as CEO in early 2015, he has assembled a first-rate senior management team, overseen the evolution of the company’s shunt products and clinical indications, including demonstration of clinical proof-of-principle and regulatory approval for a pivotal trial, and successfully concluded B and C round private equity financings.